Comparative Effectiveness of Telitacicept and Enteric-Coated Budesonide in IgA Nephropathy: The Role of Baseline Proteinuria in Treatment Response
Journal of Inflammation Research · 2026-11 · Volume 19 · 1-14
DOI: 10.2147/jir.s652534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-11. Verfasst von Xiaoxuan Zhao und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhao, X., Hou, Y., Liu, L., Zhang, R., Yang, Y., & Sun, W. (2026). Comparative Effectiveness of Telitacicept and Enteric-Coated Budesonide in IgA Nephropathy: The Role of Baseline Proteinuria in Treatment Response. Journal of Inflammation Research, Volume 19, 1-14. https://doi.org/10.2147/jir.s652534
Vancouver
Zhao X, Hou Y, Liu L, Zhang R, Yang Y, Sun W. Comparative Effectiveness of Telitacicept and Enteric-Coated Budesonide in IgA Nephropathy: The Role of Baseline Proteinuria in Treatment Response. Journal of Inflammation Research. 2026;Volume 19:1-14. doi:10.2147/jir.s652534
BibTeX
@article{Zhao2026,
author = {Zhao, Xiaoxuan and Hou, Yue and Liu, Liying and Zhang, Ran and Yang, Yi and Sun, Weixia},
title = {Comparative Effectiveness of Telitacicept and Enteric-Coated Budesonide in IgA Nephropathy: The Role of Baseline Proteinuria in Treatment Response},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jir.s652534}
}
EUVIMED